Defending 'Salt Patents' In Hatch-Waxman Cases
After Pfizer Inc. v. Apotex Inc., 480 F.3d 1348 (Fed. Cir. 2007), reh'g denied, 488 F.3d 1377 (Fed. Cir. 2007) ("Norvasc decision"), there was an apparent drop in cases involving salt patents,...To view the full article, register now.
Already a subscriber? Click here to view full article